ARTICLE ORIGINAL / ORIGINAL ARTICLE BENEFIT AND TOLERABILITY OF THE COADMINISTRATION OF EZETIMIBE AND ATORVASTATIN IN ACUTE CORONARY SYNDROME PATIENTS

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.

  2008cited by this paper
• Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

  2008cited by this paper
• Analyses of cancer data from three ezetimibe trials.

  2008cited by this paper
• Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial.

  2005cited by this paper
• A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.

  2004cited by this paper
• Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia: A Prospective, Randomized, Double-Blind Trial

  2003cited by this paper
• Scientific and therapeutic advances in antiplatelet therapy

  2003cited by this paper
• Widespread coronary inflammation in unstable angina.

  2003cited by this paper
• Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive protein.

  2003cited by this paper
• Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia.

  2002cited by this paper
• Multiple Atherosclerotic Plaque Rupture in Acute Coronary Syndrome: A Three-Vessel Intravascular Ultrasound Study

  2002cited by this paper
• Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins.

  2001cited by this paper
• Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study.

  2001cited by this paper
• The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.

  2000cited by this paper
• Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin.

  1998cited by this paper
• Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

  1998cited by this paper

• No citing papers are available for this paper.